US Stock MarketDetailed Quotes

LXEO Lexeo Therapeutics

Watchlist

11.690
-0.010-0.09%

Close Aug 14 16:00 ET

11.690
0.0000.00%

Post 16:01 ET

386.48MMarket Cap-5002P/E (TTM)

Lexeo Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Total revenue

-60.53%654K

531K

Operating revenue

--0

-60.53%654K

--0

--531K

Cost of revenue

Gross profit

Operating expense

68.52%23.55M

20.74%23.29M

12.02%68.51M

-1.47%14.97M

12.55%20.27M

-8.95%13.98M

19.29M

16.96%61.16M

15.2M

18.01M

Selling and administrative expenses

155.20%6.99M

164.69%7.55M

28.18%15.38M

77.53%6.76M

14.18%3.03M

-11.10%2.74M

--2.85M

67.31%12M

--3.81M

--2.65M

-General and administrative expense

155.20%6.99M

164.69%7.55M

28.18%15.38M

77.53%6.76M

14.18%3.03M

-11.10%2.74M

--2.85M

67.31%12M

--3.81M

--2.65M

Research and development costs

47.38%16.56M

-4.23%15.74M

8.07%53.13M

-27.90%8.21M

12.26%17.25M

-8.40%11.24M

--16.44M

8.96%49.16M

--11.39M

--15.36M

Operating profit

-68.52%-23.55M

-20.74%-23.29M

-13.23%-68.51M

1.47%-14.97M

-15.96%-20.27M

8.73%-13.98M

-19.29M

-19.50%-60.51M

-15.2M

-17.48M

Net non-operating interest income expense

330.73%2.31M

153.38%1.61M

115.72%2.66M

69.13%1.05M

2.11%436K

219.64%537K

637K

8,126.67%1.23M

622K

427K

Non-operating interest income

297.97%2.35M

140.32%1.65M

116.38%2.87M

63.02%1.1M

7.02%488K

233.33%590K

--687K

8,733.33%1.33M

--676K

--456K

Non-operating interest expense

-33.96%35K

-26.00%37K

125.27%205K

-7.41%50K

79.31%52K

488.89%53K

--50K

--91K

--54K

--29K

Other net income (expense)

66.67%-1K

-25.00%-5K

-27,050.00%-543K

-265K

-271K

-3K

-4K

-2K

Gain on sale of security

----

---530K

---258K

---272K

----

Other non- operating income (expenses)

66.67%-1K

-25.00%-5K

-550.00%-13K

---7K

--1K

---3K

---4K

---2K

----

Income before tax

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

-17.06M

Income tax

Net income

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

-17.06M

Net income continuous Operations

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

---18.66M

-17.10%-59.28M

---14.58M

---17.06M

Minority interest income

Net income attributable to the parent company

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

-17.06M

Preferred stock dividends

Other preferred stock dividends

Net income attributable to common stockholders

-58.01%-21.24M

-16.21%-21.68M

-12.01%-66.39M

2.68%-14.19M

-17.90%-20.11M

11.24%-13.44M

-18.66M

-17.10%-59.28M

-14.58M

-17.06M

Basic earnings per share

-19.85%-0.64

-3.88%-0.77

-426.51%-12.4

8.07%-0.5324

-17.90%-0.7989

11.24%-0.534

-0.7413

-17.10%-2.3551

-0.5792

-0.6776

Diluted earnings per share

-19.85%-0.64

-3.88%-0.77

-426.51%-12.4

8.07%-0.5324

-17.90%-0.7989

11.24%-0.534

-0.7413

-17.10%-2.3551

-0.5792

-0.6776

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Total revenue	0	0	0	0	0	0	0	-60.53%654K	0	531K
Operating revenue	--0	--0	--0	--0	--0	--0	--0	-60.53%654K	--0	--531K
Cost of revenue
Gross profit
Operating expense	68.52%23.55M	20.74%23.29M	12.02%68.51M	-1.47%14.97M	12.55%20.27M	-8.95%13.98M	19.29M	16.96%61.16M	15.2M	18.01M
Selling and administrative expenses	155.20%6.99M	164.69%7.55M	28.18%15.38M	77.53%6.76M	14.18%3.03M	-11.10%2.74M	--2.85M	67.31%12M	--3.81M	--2.65M
-General and administrative expense	155.20%6.99M	164.69%7.55M	28.18%15.38M	77.53%6.76M	14.18%3.03M	-11.10%2.74M	--2.85M	67.31%12M	--3.81M	--2.65M
Research and development costs	47.38%16.56M	-4.23%15.74M	8.07%53.13M	-27.90%8.21M	12.26%17.25M	-8.40%11.24M	--16.44M	8.96%49.16M	--11.39M	--15.36M
Operating profit	-68.52%-23.55M	-20.74%-23.29M	-13.23%-68.51M	1.47%-14.97M	-15.96%-20.27M	8.73%-13.98M	-19.29M	-19.50%-60.51M	-15.2M	-17.48M
Net non-operating interest income expense	330.73%2.31M	153.38%1.61M	115.72%2.66M	69.13%1.05M	2.11%436K	219.64%537K	637K	8,126.67%1.23M	622K	427K
Non-operating interest income	297.97%2.35M	140.32%1.65M	116.38%2.87M	63.02%1.1M	7.02%488K	233.33%590K	--687K	8,733.33%1.33M	--676K	--456K
Non-operating interest expense	-33.96%35K	-26.00%37K	125.27%205K	-7.41%50K	79.31%52K	488.89%53K	--50K	--91K	--54K	--29K
Other net income (expense)	66.67%-1K	-25.00%-5K	-27,050.00%-543K	-265K	-271K	-3K	-4K	-2K
Gain on sale of security	----	----	---530K	---258K	---272K	----	----	----	----	----
Other non- operating income (expenses)	66.67%-1K	-25.00%-5K	-550.00%-13K	---7K	--1K	---3K	---4K	---2K	----	----
Income before tax	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M	-17.06M
Income tax	0	0	0	0	0	0	0	0	0	0
Net income	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M	-17.06M
Net income continuous Operations	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	---18.66M	-17.10%-59.28M	---14.58M	---17.06M
Minority interest income
Net income attributable to the parent company	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M	-17.06M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders	-58.01%-21.24M	-16.21%-21.68M	-12.01%-66.39M	2.68%-14.19M	-17.90%-20.11M	11.24%-13.44M	-18.66M	-17.10%-59.28M	-14.58M	-17.06M
Basic earnings per share	-19.85%-0.64	-3.88%-0.77	-426.51%-12.4	8.07%-0.5324	-17.90%-0.7989	11.24%-0.534	-0.7413	-17.10%-2.3551	-0.5792	-0.6776
Diluted earnings per share	-19.85%-0.64	-3.88%-0.77	-426.51%-12.4	8.07%-0.5324	-17.90%-0.7989	11.24%-0.534	-0.7413	-17.10%-2.3551	-0.5792	-0.6776
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall